Fed. Circ. Backs Oxford Nanopore's DNA Tech IP Trial Victory
The Federal Circuit on Tuesday upheld a jury verdict that DNA analysis patents Pacific Biosciences asserted against Oxford Nanopore Technologies Inc. are invalid for lack of enablement, rejecting PacBio's argument that...To view the full article, register now.
Already a subscriber? Click here to view full article